StonvexLoading…
StonvexStonvexStonvexCore line items from AAMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $563.70M | $505.60M | $426.60M | $417.20M |
Operating Income | $132.10M | $135.50M | $106.00M | $167.90M |
Net Income | $80.00M | $85.00M | $65.80M | $100.60M |
EPS (Diluted) | $2.21 | $2.22 | $1.55 | $2.33 |
Total Assets | $677.00M | $703.20M | $611.40M | $518.70M |
Total Liabilities | $593.00M | $616.10M | $561.90M | $540.30M |
Cash & Equivalents | $124.40M | $98.50M | $147.60M | $121.20M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 36.22M | 38.33M | 42.54M | 43.16M |